Glaucoma Trial, Recruiting NCT04553523 Sponsor: Alcon Research Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT04553523
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a cataract that can be treated with surgery, where even with glasses or contact lenses their vision is still 20/40 or worse (meaning they would struggle to read a standard eye chart clearly)
  • People who have been diagnosed with a common type of glaucoma called primary open angle glaucoma, and are currently managing it with no more than 4 eye drop medications to lower eye pressure
  • People whose optic nerve (the nerve at the back of the eye) shows signs that are typical of glaucoma
  • People whose eye pressure, while on medication, is 31 mmHg or below (mmHg is the unit used to measure pressure inside the eye)

Who may not be able to join:

  • People who have a type of glaucoma where the drainage angle in the eye is closed or narrow (rather than open)
  • People who were born with glaucoma or developed it during childhood
  • People whose glaucoma was caused by another medical condition or eye problem (known as secondary glaucoma)
  • People currently using more than 4 eye pressure-lowering medications
  • People who have previously had certain laser or surgical treatments for glaucoma, including laser trabeculoplasty, trabeculectomy, tube shunts, or other similar drainage or pressure-reducing eye surgeries
  • People who have previously had surgery that involved implanting a device into, or otherwise operating on, specific drainage structures inside the eye (confirm with trial site)
  • There may be additional criteria not listed here that the trial site will assess

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Clinical Project Lead, CDMA Surgical, Alcon Research

Phone: 1-888-451-3937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Alcon Research
Registry
ClinicalTrials.gov
Start date
25 August 2020
Est. completion
1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of occurrence of clinically significant device malposition associated with clinical sequelae

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov